nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.081	0.282	CbGbCtD
Olopatadine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0547	0.19	CbGbCtD
Olopatadine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0522	0.182	CbGbCtD
Olopatadine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0465	0.162	CbGbCtD
Olopatadine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0273	0.0949	CbGbCtD
Olopatadine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0258	0.0897	CbGbCtD
Olopatadine—S100A2—respiratory system—chronic obstructive pulmonary disease	0.0166	0.0888	CbGeAlD
Olopatadine—S100A2—bronchus—chronic obstructive pulmonary disease	0.0136	0.0731	CbGeAlD
Olopatadine—S100A13—respiratory system—chronic obstructive pulmonary disease	0.0135	0.0726	CbGeAlD
Olopatadine—S100A1—connective tissue—chronic obstructive pulmonary disease	0.0134	0.072	CbGeAlD
Olopatadine—S100A12—respiratory system—chronic obstructive pulmonary disease	0.0134	0.0716	CbGeAlD
Olopatadine—S100A1—bronchus—chronic obstructive pulmonary disease	0.0126	0.0673	CbGeAlD
Olopatadine—S100A2—trachea—chronic obstructive pulmonary disease	0.0122	0.0656	CbGeAlD
Olopatadine—S100A13—connective tissue—chronic obstructive pulmonary disease	0.0119	0.0639	CbGeAlD
Olopatadine—S100A12—connective tissue—chronic obstructive pulmonary disease	0.0118	0.063	CbGeAlD
Olopatadine—S100B—connective tissue—chronic obstructive pulmonary disease	0.0116	0.0622	CbGeAlD
Olopatadine—S100A1—trachea—chronic obstructive pulmonary disease	0.0113	0.0604	CbGeAlD
Olopatadine—S100A13—smooth muscle tissue—chronic obstructive pulmonary disease	0.0109	0.0584	CbGeAlD
Olopatadine—S100A2—lung—chronic obstructive pulmonary disease	0.0088	0.0472	CbGeAlD
Olopatadine—S100A2—p73 transcription factor network—SERPINA1—chronic obstructive pulmonary disease	0.00812	0.0593	CbGpPWpGaD
Olopatadine—S100A13—lung—chronic obstructive pulmonary disease	0.00719	0.0385	CbGeAlD
Olopatadine—S100A12—lung—chronic obstructive pulmonary disease	0.00709	0.038	CbGeAlD
Olopatadine—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00431	0.0314	CbGpPWpGaD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—LY96—chronic obstructive pulmonary disease	0.00425	0.031	CbGpPWpGaD
Olopatadine—S100A12—MyD88-independent cascade—LY96—chronic obstructive pulmonary disease	0.00408	0.0297	CbGpPWpGaD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—LY96—chronic obstructive pulmonary disease	0.00402	0.0293	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—HDAC2—chronic obstructive pulmonary disease	0.004	0.0292	CbGpPWpGaD
Olopatadine—S100B—MyD88-independent cascade—LY96—chronic obstructive pulmonary disease	0.00385	0.0281	CbGpPWpGaD
Olopatadine—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00381	0.0278	CbGpPWpGaD
Olopatadine—S100A12—Activated TLR4 signalling—LY96—chronic obstructive pulmonary disease	0.00367	0.0267	CbGpPWpGaD
Olopatadine—S100B—Activated TLR4 signalling—LY96—chronic obstructive pulmonary disease	0.00347	0.0253	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—LY96—chronic obstructive pulmonary disease	0.00345	0.0252	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—LY96—chronic obstructive pulmonary disease	0.00326	0.0238	CbGpPWpGaD
Olopatadine—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00311	0.0227	CbGpPWpGaD
Olopatadine—S100A2—p73 transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.00309	0.0225	CbGpPWpGaD
Olopatadine—S100A12—Toll-Like Receptors Cascades—LY96—chronic obstructive pulmonary disease	0.00307	0.0224	CbGpPWpGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—LY96—chronic obstructive pulmonary disease	0.0029	0.0212	CbGpPWpGaD
Olopatadine—HRH1—respiratory system—chronic obstructive pulmonary disease	0.0027	0.0145	CbGeAlD
Olopatadine—HRH1—connective tissue—chronic obstructive pulmonary disease	0.00238	0.0128	CbGeAlD
Olopatadine—HRH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00218	0.0117	CbGeAlD
Olopatadine—HRH1—trachea—chronic obstructive pulmonary disease	0.002	0.0107	CbGeAlD
Olopatadine—S100A2—Direct p53 effectors—SERPINE1—chronic obstructive pulmonary disease	0.00196	0.0143	CbGpPWpGaD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—TLR2—chronic obstructive pulmonary disease	0.00193	0.0141	CbGpPWpGaD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—TLR2—chronic obstructive pulmonary disease	0.00182	0.0133	CbGpPWpGaD
Olopatadine—S100A12—Activated TLR4 signalling—TLR2—chronic obstructive pulmonary disease	0.00166	0.0121	CbGpPWpGaD
Olopatadine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00158	0.0115	CbGpPWpGaD
Olopatadine—S100B—Activated TLR4 signalling—TLR2—chronic obstructive pulmonary disease	0.00157	0.0115	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—TLR2—chronic obstructive pulmonary disease	0.00157	0.0114	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—TLR2—chronic obstructive pulmonary disease	0.00148	0.0108	CbGpPWpGaD
Olopatadine—HRH1—lung—chronic obstructive pulmonary disease	0.00143	0.00769	CbGeAlD
Olopatadine—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.0014	0.00373	CcSEcCtD
Olopatadine—S100A12—Toll-Like Receptors Cascades—TLR2—chronic obstructive pulmonary disease	0.00139	0.0102	CbGpPWpGaD
Olopatadine—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00139	0.0037	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00366	CcSEcCtD
Olopatadine—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.00137	0.00364	CcSEcCtD
Olopatadine—Infestation—Montelukast—chronic obstructive pulmonary disease	0.00137	0.00364	CcSEcCtD
Olopatadine—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00362	CcSEcCtD
Olopatadine—Urinary tract infection—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00362	CcSEcCtD
Olopatadine—Urinary tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00362	CcSEcCtD
Olopatadine—Conjunctivitis—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00362	CcSEcCtD
Olopatadine—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.00133	0.00354	CcSEcCtD
Olopatadine—S100B—Toll-Like Receptors Cascades—TLR2—chronic obstructive pulmonary disease	0.00132	0.00962	CbGpPWpGaD
Olopatadine—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00349	CcSEcCtD
Olopatadine—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00349	CcSEcCtD
Olopatadine—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00131	0.00349	CcSEcCtD
Olopatadine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00129	0.00345	CcSEcCtD
Olopatadine—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00344	CcSEcCtD
Olopatadine—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.00128	0.00342	CcSEcCtD
Olopatadine—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00342	CcSEcCtD
Olopatadine—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00342	CcSEcCtD
Olopatadine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00127	0.0034	CcSEcCtD
Olopatadine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00126	0.00336	CcSEcCtD
Olopatadine—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00335	CcSEcCtD
Olopatadine—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00335	CcSEcCtD
Olopatadine—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00124	0.00332	CcSEcCtD
Olopatadine—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00124	0.00332	CcSEcCtD
Olopatadine—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00331	CcSEcCtD
Olopatadine—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.0033	CcSEcCtD
Olopatadine—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00328	CcSEcCtD
Olopatadine—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00326	CcSEcCtD
Olopatadine—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00325	CcSEcCtD
Olopatadine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.00121	0.00884	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—EGFR—chronic obstructive pulmonary disease	0.00121	0.00883	CbGpPWpGaD
Olopatadine—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.00121	0.00322	CcSEcCtD
Olopatadine—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.00322	CcSEcCtD
Olopatadine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.0012	0.0032	CcSEcCtD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—TLR4—chronic obstructive pulmonary disease	0.00119	0.00869	CbGpPWpGaD
Olopatadine—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00316	CcSEcCtD
Olopatadine—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00118	0.00314	CcSEcCtD
Olopatadine—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00314	CcSEcCtD
Olopatadine—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00313	CcSEcCtD
Olopatadine—S100B—Signaling by ERBB4—KL—chronic obstructive pulmonary disease	0.00117	0.00852	CbGpPWpGaD
Olopatadine—Clomipramine—GSTP1—chronic obstructive pulmonary disease	0.00116	0.0811	CrCbGaD
Olopatadine—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00116	0.0031	CcSEcCtD
Olopatadine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00116	0.00309	CcSEcCtD
Olopatadine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00115	0.00306	CcSEcCtD
Olopatadine—S100A12—MyD88-independent cascade—TLR4—chronic obstructive pulmonary disease	0.00114	0.00834	CbGpPWpGaD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00305	CcSEcCtD
Olopatadine—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00302	CcSEcCtD
Olopatadine—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00302	CcSEcCtD
Olopatadine—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00301	CcSEcCtD
Olopatadine—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00301	CcSEcCtD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—TLR4—chronic obstructive pulmonary disease	0.00113	0.00822	CbGpPWpGaD
Olopatadine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00112	0.003	CcSEcCtD
Olopatadine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00111	0.00297	CcSEcCtD
Olopatadine—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00296	CcSEcCtD
Olopatadine—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.0011	0.00295	CcSEcCtD
Olopatadine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.0011	0.00295	CcSEcCtD
Olopatadine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.0011	0.00295	CcSEcCtD
Olopatadine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.00294	CcSEcCtD
Olopatadine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.0011	0.00293	CcSEcCtD
Olopatadine—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.00292	CcSEcCtD
Olopatadine—S100B—MyD88-independent cascade—TLR4—chronic obstructive pulmonary disease	0.00108	0.00789	CbGpPWpGaD
Olopatadine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00108	0.00288	CcSEcCtD
Olopatadine—Cyclobenzaprine—CYP1A2—chronic obstructive pulmonary disease	0.00108	0.0753	CrCbGaD
Olopatadine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00107	0.00286	CcSEcCtD
Olopatadine—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00285	CcSEcCtD
Olopatadine—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00285	CcSEcCtD
Olopatadine—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00285	CcSEcCtD
Olopatadine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00284	CcSEcCtD
Olopatadine—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00281	CcSEcCtD
Olopatadine—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00281	CcSEcCtD
Olopatadine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00105	0.0028	CcSEcCtD
Olopatadine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.0028	CcSEcCtD
Olopatadine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00104	0.00278	CcSEcCtD
Olopatadine—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.00104	0.00277	CcSEcCtD
Olopatadine—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00276	CcSEcCtD
Olopatadine—S100A12—Activated TLR4 signalling—TLR4—chronic obstructive pulmonary disease	0.00103	0.0075	CbGpPWpGaD
Olopatadine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00274	CcSEcCtD
Olopatadine—HRH1—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.00102	0.00745	CbGpPWpGaD
Olopatadine—S100A2—Direct p53 effectors—TP53—chronic obstructive pulmonary disease	0.00102	0.00741	CbGpPWpGaD
Olopatadine—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00101	0.0027	CcSEcCtD
Olopatadine—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.0027	CcSEcCtD
Olopatadine—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00269	CcSEcCtD
Olopatadine—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000995	0.00266	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—LY96—chronic obstructive pulmonary disease	0.000995	0.00726	CbGpPWpGaD
Olopatadine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000989	0.00264	CcSEcCtD
Olopatadine—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000983	0.00262	CcSEcCtD
Olopatadine—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000983	0.00262	CcSEcCtD
Olopatadine—S100B—Activated TLR4 signalling—TLR4—chronic obstructive pulmonary disease	0.000973	0.00709	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—TLR4—chronic obstructive pulmonary disease	0.000967	0.00706	CbGpPWpGaD
Olopatadine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000955	0.00255	CcSEcCtD
Olopatadine—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000955	0.00255	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000951	0.00254	CcSEcCtD
Olopatadine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000951	0.00254	CcSEcCtD
Olopatadine—Cough—Formoterol—chronic obstructive pulmonary disease	0.000951	0.00254	CcSEcCtD
Olopatadine—S100B—Innate Immune System—LY96—chronic obstructive pulmonary disease	0.000941	0.00686	CbGpPWpGaD
Olopatadine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000939	0.00685	CbGpPWpGaD
Olopatadine—Cough—Montelukast—chronic obstructive pulmonary disease	0.000931	0.00249	CcSEcCtD
Olopatadine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000928	0.00248	CcSEcCtD
Olopatadine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000924	0.00247	CcSEcCtD
Olopatadine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000924	0.00247	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000921	0.00246	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000921	0.00246	CcSEcCtD
Olopatadine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000917	0.00245	CcSEcCtD
Olopatadine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000917	0.00245	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—TLR4—chronic obstructive pulmonary disease	0.000915	0.00667	CbGpPWpGaD
Olopatadine—Cyclobenzaprine—HTR2A—chronic obstructive pulmonary disease	0.000912	0.0636	CrCbGaD
Olopatadine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000907	0.00242	CcSEcCtD
Olopatadine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000907	0.00242	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000902	0.00241	CcSEcCtD
Olopatadine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000901	0.0024	CcSEcCtD
Olopatadine—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000898	0.0024	CcSEcCtD
Olopatadine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000898	0.0024	CcSEcCtD
Olopatadine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000889	0.00237	CcSEcCtD
Olopatadine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000889	0.00237	CcSEcCtD
Olopatadine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000883	0.00236	CcSEcCtD
Olopatadine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000883	0.00236	CcSEcCtD
Olopatadine—S100B—Signaling by ERBB4—ERBB3—chronic obstructive pulmonary disease	0.000875	0.00638	CbGpPWpGaD
Olopatadine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000872	0.00233	CcSEcCtD
Olopatadine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000872	0.00233	CcSEcCtD
Olopatadine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000871	0.00232	CcSEcCtD
Olopatadine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000871	0.00232	CcSEcCtD
Olopatadine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000865	0.00231	CcSEcCtD
Olopatadine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000865	0.00231	CcSEcCtD
Olopatadine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000864	0.00231	CcSEcCtD
Olopatadine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000864	0.00231	CcSEcCtD
Olopatadine—S100A12—Toll-Like Receptors Cascades—TLR4—chronic obstructive pulmonary disease	0.000862	0.00628	CbGpPWpGaD
Olopatadine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000861	0.0023	CcSEcCtD
Olopatadine—HRH1—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.000858	0.00626	CbGpPWpGaD
Olopatadine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000857	0.00229	CcSEcCtD
Olopatadine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000854	0.00228	CcSEcCtD
Olopatadine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000846	0.00226	CcSEcCtD
Olopatadine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00084	0.00224	CcSEcCtD
Olopatadine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000834	0.00223	CcSEcCtD
Olopatadine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000827	0.00221	CcSEcCtD
Olopatadine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000823	0.0022	CcSEcCtD
Olopatadine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000816	0.00595	CbGpPWpGaD
Olopatadine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000816	0.00218	CcSEcCtD
Olopatadine—S100B—Toll-Like Receptors Cascades—TLR4—chronic obstructive pulmonary disease	0.000815	0.00594	CbGpPWpGaD
Olopatadine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000812	0.00217	CcSEcCtD
Olopatadine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000799	0.00213	CcSEcCtD
Olopatadine—HRH1—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000798	0.00582	CbGpPWpGaD
Olopatadine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000793	0.00212	CcSEcCtD
Olopatadine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000793	0.00212	CcSEcCtD
Olopatadine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000791	0.00211	CcSEcCtD
Olopatadine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000791	0.00211	CcSEcCtD
Olopatadine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00078	0.00208	CcSEcCtD
Olopatadine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000774	0.00207	CcSEcCtD
Olopatadine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000773	0.00206	CcSEcCtD
Olopatadine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000771	0.00206	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000768	0.00205	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000768	0.00205	CcSEcCtD
Olopatadine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000767	0.00205	CcSEcCtD
Olopatadine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000767	0.00205	CcSEcCtD
Olopatadine—Pain—Formoterol—chronic obstructive pulmonary disease	0.00076	0.00203	CcSEcCtD
Olopatadine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00076	0.00203	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000752	0.00201	CcSEcCtD
Olopatadine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000751	0.002	CcSEcCtD
Olopatadine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000749	0.002	CcSEcCtD
Olopatadine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000746	0.00199	CcSEcCtD
Olopatadine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000745	0.00199	CcSEcCtD
Olopatadine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000743	0.00198	CcSEcCtD
Olopatadine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000742	0.00542	CbGpPWpGaD
Olopatadine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000737	0.00197	CcSEcCtD
Olopatadine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000736	0.00196	CcSEcCtD
Olopatadine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000734	0.00196	CcSEcCtD
Olopatadine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000733	0.00196	CcSEcCtD
Olopatadine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000733	0.00196	CcSEcCtD
Olopatadine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000732	0.00195	CcSEcCtD
Olopatadine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000729	0.00194	CcSEcCtD
Olopatadine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000727	0.00194	CcSEcCtD
Olopatadine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000727	0.00194	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000725	0.00193	CcSEcCtD
Olopatadine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000724	0.00193	CcSEcCtD
Olopatadine—Thiothixene—CYP1A2—chronic obstructive pulmonary disease	0.000718	0.0501	CrCbGaD
Olopatadine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000718	0.00192	CcSEcCtD
Olopatadine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000712	0.0019	CcSEcCtD
Olopatadine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000711	0.00519	CbGpPWpGaD
Olopatadine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000703	0.00188	CcSEcCtD
Olopatadine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000703	0.00188	CcSEcCtD
Olopatadine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000703	0.00188	CcSEcCtD
Olopatadine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000703	0.00188	CcSEcCtD
Olopatadine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000701	0.00187	CcSEcCtD
Olopatadine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000695	0.00185	CcSEcCtD
Olopatadine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000694	0.00185	CcSEcCtD
Olopatadine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000694	0.00185	CcSEcCtD
Olopatadine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000692	0.00185	CcSEcCtD
Olopatadine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00069	0.00184	CcSEcCtD
Olopatadine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000689	0.00184	CcSEcCtD
Olopatadine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000689	0.00184	CcSEcCtD
Olopatadine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000687	0.00183	CcSEcCtD
Olopatadine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000682	0.00498	CbGpPWpGaD
Olopatadine—HRH1—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000671	0.00489	CbGpPWpGaD
Olopatadine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000664	0.00177	CcSEcCtD
Olopatadine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000664	0.00177	CcSEcCtD
Olopatadine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000656	0.00479	CbGpPWpGaD
Olopatadine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000655	0.00175	CcSEcCtD
Olopatadine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000655	0.00175	CcSEcCtD
Olopatadine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000655	0.00175	CcSEcCtD
Olopatadine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000653	0.00174	CcSEcCtD
Olopatadine—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000653	0.00174	CcSEcCtD
Olopatadine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000642	0.00171	CcSEcCtD
Olopatadine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000638	0.0017	CcSEcCtD
Olopatadine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000638	0.0017	CcSEcCtD
Olopatadine—Acepromazine—HTR2A—chronic obstructive pulmonary disease	0.00063	0.0439	CrCbGaD
Olopatadine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000629	0.00168	CcSEcCtD
Olopatadine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000629	0.00168	CcSEcCtD
Olopatadine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000625	0.00167	CcSEcCtD
Olopatadine—Clomipramine—SLC6A4—chronic obstructive pulmonary disease	0.000623	0.0435	CrCbGaD
Olopatadine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000619	0.00165	CcSEcCtD
Olopatadine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000616	0.00164	CcSEcCtD
Olopatadine—Nortriptyline—SLC6A4—chronic obstructive pulmonary disease	0.000609	0.0425	CrCbGaD
Olopatadine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000608	0.00162	CcSEcCtD
Olopatadine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000608	0.00162	CcSEcCtD
Olopatadine—Thiothixene—HTR2A—chronic obstructive pulmonary disease	0.000606	0.0423	CrCbGaD
Olopatadine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000602	0.00161	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000601	0.00438	CbGpPWpGaD
Olopatadine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000596	0.00159	CcSEcCtD
Olopatadine—S100A12—Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.000596	0.00435	CbGpPWpGaD
Olopatadine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000594	0.00159	CcSEcCtD
Olopatadine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000593	0.00432	CbGpPWpGaD
Olopatadine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00059	0.00157	CcSEcCtD
Olopatadine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000588	0.00157	CcSEcCtD
Olopatadine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000588	0.00157	CcSEcCtD
Olopatadine—S100A12—Immune System—LY96—chronic obstructive pulmonary disease	0.00058	0.00423	CbGpPWpGaD
Olopatadine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000576	0.00154	CcSEcCtD
Olopatadine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000575	0.00153	CcSEcCtD
Olopatadine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000569	0.00415	CbGpPWpGaD
Olopatadine—Clomipramine—CYP1A2—chronic obstructive pulmonary disease	0.000568	0.0396	CrCbGaD
Olopatadine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000565	0.00151	CcSEcCtD
Olopatadine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000565	0.00151	CcSEcCtD
Olopatadine—S100B—Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.000563	0.00411	CbGpPWpGaD
Olopatadine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000561	0.0015	CcSEcCtD
Olopatadine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000561	0.0015	CcSEcCtD
Olopatadine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00056	0.0015	CcSEcCtD
Olopatadine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00056	0.0015	CcSEcCtD
Olopatadine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.00056	0.00149	CcSEcCtD
Olopatadine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000557	0.00149	CcSEcCtD
Olopatadine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000557	0.00149	CcSEcCtD
Olopatadine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000556	0.00148	CcSEcCtD
Olopatadine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000555	0.00148	CcSEcCtD
Olopatadine—Nortriptyline—CYP1A2—chronic obstructive pulmonary disease	0.000555	0.0387	CrCbGaD
Olopatadine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000554	0.00148	CcSEcCtD
Olopatadine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000549	0.00147	CcSEcCtD
Olopatadine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000549	0.00146	CcSEcCtD
Olopatadine—S100B—Immune System—LY96—chronic obstructive pulmonary disease	0.000548	0.004	CbGpPWpGaD
Olopatadine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000548	0.00146	CcSEcCtD
Olopatadine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000547	0.00146	CcSEcCtD
Olopatadine—Doxepin—SLC6A4—chronic obstructive pulmonary disease	0.000547	0.0381	CrCbGaD
Olopatadine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000546	0.00146	CcSEcCtD
Olopatadine—S100A12—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—chronic obstructive pulmonary disease	0.000544	0.00397	CbGpPWpGaD
Olopatadine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000539	0.00393	CbGpPWpGaD
Olopatadine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000534	0.00142	CcSEcCtD
Olopatadine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000532	0.00142	CcSEcCtD
Olopatadine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000529	0.00141	CcSEcCtD
Olopatadine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000529	0.00141	CcSEcCtD
Olopatadine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000528	0.00141	CcSEcCtD
Olopatadine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000528	0.00141	CcSEcCtD
Olopatadine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000526	0.0014	CcSEcCtD
Olopatadine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000517	0.00138	CcSEcCtD
Olopatadine—S100B—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—chronic obstructive pulmonary disease	0.000514	0.00375	CbGpPWpGaD
Olopatadine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000499	0.00133	CcSEcCtD
Olopatadine—Doxepin—CYP1A2—chronic obstructive pulmonary disease	0.000498	0.0347	CrCbGaD
Olopatadine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000496	0.00132	CcSEcCtD
Olopatadine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000496	0.00362	CbGpPWpGaD
Olopatadine—S100A12—MyD88 cascade initiated on plasma membrane—IL6—chronic obstructive pulmonary disease	0.000492	0.00359	CbGpPWpGaD
Olopatadine—S100A12—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—chronic obstructive pulmonary disease	0.000488	0.00356	CbGpPWpGaD
Olopatadine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000482	0.00129	CcSEcCtD
Olopatadine—Clomipramine—HTR2A—chronic obstructive pulmonary disease	0.000479	0.0334	CrCbGaD
Olopatadine—S100A12—MyD88 dependent cascade initiated on endosome—IL6—chronic obstructive pulmonary disease	0.000479	0.00349	CbGpPWpGaD
Olopatadine—Chlorprothixene—HTR2A—chronic obstructive pulmonary disease	0.000477	0.0333	CrCbGaD
Olopatadine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000477	0.00348	CbGpPWpGaD
Olopatadine—Nortriptyline—HTR2A—chronic obstructive pulmonary disease	0.000468	0.0326	CrCbGaD
Olopatadine—S100B—MyD88 cascade initiated on plasma membrane—IL6—chronic obstructive pulmonary disease	0.000465	0.00339	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 9 (TLR9) Cascade—IL6—chronic obstructive pulmonary disease	0.000462	0.00337	CbGpPWpGaD
Olopatadine—S100B—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—chronic obstructive pulmonary disease	0.000461	0.00336	CbGpPWpGaD
Olopatadine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.00046	0.00123	CcSEcCtD
Olopatadine—S100A12—MyD88:Mal cascade initiated on plasma membrane—IL6—chronic obstructive pulmonary disease	0.000454	0.00331	CbGpPWpGaD
Olopatadine—S100B—MyD88 dependent cascade initiated on endosome—IL6—chronic obstructive pulmonary disease	0.000453	0.0033	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000452	0.00329	CbGpPWpGaD
Olopatadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000446	0.00326	CbGpPWpGaD
Olopatadine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000445	0.00119	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 9 (TLR9) Cascade—IL6—chronic obstructive pulmonary disease	0.000437	0.00319	CbGpPWpGaD
Olopatadine—S100A12—MyD88-independent cascade—IL6—chronic obstructive pulmonary disease	0.000436	0.00318	CbGpPWpGaD
Olopatadine—Acepromazine—ALB—chronic obstructive pulmonary disease	0.000431	0.0301	CrCbGaD
Olopatadine—S100B—MyD88:Mal cascade initiated on plasma membrane—IL6—chronic obstructive pulmonary disease	0.000429	0.00313	CbGpPWpGaD
Olopatadine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000429	0.00114	CcSEcCtD
Olopatadine—S100B—Innate Immune System—TLR2—chronic obstructive pulmonary disease	0.000427	0.00312	CbGpPWpGaD
Olopatadine—Imipramine—SLC6A4—chronic obstructive pulmonary disease	0.000425	0.0297	CrCbGaD
Olopatadine—S100A12—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000425	0.0031	CbGpPWpGaD
Olopatadine—Amitriptyline—SLC6A4—chronic obstructive pulmonary disease	0.000423	0.0295	CrCbGaD
Olopatadine—Doxepin—HTR2A—chronic obstructive pulmonary disease	0.00042	0.0293	CrCbGaD
Olopatadine—Thiothixene—ALB—chronic obstructive pulmonary disease	0.000415	0.0289	CrCbGaD
Olopatadine—S100B—MyD88-independent cascade—IL6—chronic obstructive pulmonary disease	0.000412	0.003	CbGpPWpGaD
Olopatadine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000412	0.0011	CcSEcCtD
Olopatadine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000404	0.00108	CcSEcCtD
Olopatadine—S100B—Innate Immune System—KL—chronic obstructive pulmonary disease	0.000402	0.00293	CbGpPWpGaD
Olopatadine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000398	0.00106	CcSEcCtD
Olopatadine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000397	0.00106	CcSEcCtD
Olopatadine—S100A12—Activated TLR4 signalling—IL6—chronic obstructive pulmonary disease	0.000392	0.00286	CbGpPWpGaD
Olopatadine—Imipramine—CYP1A2—chronic obstructive pulmonary disease	0.000387	0.027	CrCbGaD
Olopatadine—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000387	0.00103	CcSEcCtD
Olopatadine—Amitriptyline—CYP1A2—chronic obstructive pulmonary disease	0.000385	0.0268	CrCbGaD
Olopatadine—S100B—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	0.00038	0.00277	CbGpPWpGaD
Olopatadine—S100B—Activated TLR4 signalling—IL6—chronic obstructive pulmonary disease	0.000371	0.0027	CbGpPWpGaD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—IL6—chronic obstructive pulmonary disease	0.000369	0.00269	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000364	0.00266	CbGpPWpGaD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000363	0.000968	CcSEcCtD
Olopatadine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000361	0.000963	CcSEcCtD
Olopatadine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000355	0.000947	CcSEcCtD
Olopatadine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00035	0.00256	CbGpPWpGaD
Olopatadine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00035	0.000934	CcSEcCtD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—IL6—chronic obstructive pulmonary disease	0.000349	0.00254	CbGpPWpGaD
Olopatadine—Infection—Prednisone—chronic obstructive pulmonary disease	0.000348	0.000928	CcSEcCtD
Olopatadine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000343	0.000916	CcSEcCtD
Olopatadine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00034	0.000907	CcSEcCtD
Olopatadine—S100A12—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	0.000328	0.00239	CbGpPWpGaD
Olopatadine—Clomipramine—ALB—chronic obstructive pulmonary disease	0.000328	0.0229	CrCbGaD
Olopatadine—Imipramine—HTR2A—chronic obstructive pulmonary disease	0.000327	0.0228	CrCbGaD
Olopatadine—Amitriptyline—HTR2A—chronic obstructive pulmonary disease	0.000325	0.0227	CrCbGaD
Olopatadine—Nortriptyline—ALB—chronic obstructive pulmonary disease	0.00032	0.0223	CrCbGaD
Olopatadine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000318	0.00085	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.000318	0.00232	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000314	0.00229	CbGpPWpGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	0.00031	0.00226	CbGpPWpGaD
Olopatadine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000304	0.00081	CcSEcCtD
Olopatadine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000303	0.00081	CcSEcCtD
Olopatadine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000302	0.000805	CcSEcCtD
Olopatadine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000302	0.000805	CcSEcCtD
Olopatadine—S100B—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	0.000301	0.0022	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	0.000292	0.00213	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CRP—chronic obstructive pulmonary disease	0.000291	0.00212	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00029	0.00211	CbGpPWpGaD
Olopatadine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000288	0.00077	CcSEcCtD
Olopatadine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000286	0.000764	CcSEcCtD
Olopatadine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000286	0.000763	CcSEcCtD
Olopatadine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000283	0.00207	CbGpPWpGaD
Olopatadine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00028	0.00204	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—TLR4—chronic obstructive pulmonary disease	0.000279	0.00204	CbGpPWpGaD
Olopatadine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000277	0.000738	CcSEcCtD
Olopatadine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000277	0.000738	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000276	0.00201	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CRP—chronic obstructive pulmonary disease	0.000275	0.00201	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000269	0.00196	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—TLR4—chronic obstructive pulmonary disease	0.000264	0.00192	CbGpPWpGaD
Olopatadine—S100A12—Immune System—TLR2—chronic obstructive pulmonary disease	0.000263	0.00192	CbGpPWpGaD
Olopatadine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000258	0.000688	CcSEcCtD
Olopatadine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000255	0.00186	CbGpPWpGaD
Olopatadine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000251	0.00067	CcSEcCtD
Olopatadine—S100B—Immune System—TLR2—chronic obstructive pulmonary disease	0.000249	0.00181	CbGpPWpGaD
Olopatadine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000248	0.000661	CcSEcCtD
Olopatadine—S100A12—Immune System—KL—chronic obstructive pulmonary disease	0.000247	0.0018	CbGpPWpGaD
Olopatadine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000239	0.000639	CcSEcCtD
Olopatadine—S100B—Immune System—KL—chronic obstructive pulmonary disease	0.000234	0.00171	CbGpPWpGaD
Olopatadine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000231	0.000618	CcSEcCtD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00023	0.00168	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000228	0.00166	CbGpPWpGaD
Olopatadine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000223	0.000594	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000222	0.00162	CbGpPWpGaD
Olopatadine—Amitriptyline—ALB—chronic obstructive pulmonary disease	0.000222	0.0155	CrCbGaD
Olopatadine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000221	0.000589	CcSEcCtD
Olopatadine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00022	0.000588	CcSEcCtD
Olopatadine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000585	CcSEcCtD
Olopatadine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000208	0.000555	CcSEcCtD
Olopatadine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000206	0.0015	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000205	0.00149	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000204	0.00149	CbGpPWpGaD
Olopatadine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000203	0.00148	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD8A—chronic obstructive pulmonary disease	0.000199	0.00145	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.000199	0.00145	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000197	0.00144	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD8A—chronic obstructive pulmonary disease	0.000189	0.00138	CbGpPWpGaD
Olopatadine—S100A12—Immune System—ERBB3—chronic obstructive pulmonary disease	0.000185	0.00135	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000178	0.0013	CbGpPWpGaD
Olopatadine—S100B—Immune System—ERBB3—chronic obstructive pulmonary disease	0.000175	0.00128	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CRP—chronic obstructive pulmonary disease	0.00017	0.00124	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000169	0.00123	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000168	0.00122	CbGpPWpGaD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000167	0.00122	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000163	0.00119	CbGpPWpGaD
Olopatadine—S100A12—Immune System—TLR4—chronic obstructive pulmonary disease	0.000163	0.00119	CbGpPWpGaD
Olopatadine—S100B—Immune System—CRP—chronic obstructive pulmonary disease	0.00016	0.00117	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000154	0.00112	CbGpPWpGaD
Olopatadine—S100B—Immune System—TLR4—chronic obstructive pulmonary disease	0.000154	0.00112	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000151	0.0011	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000151	0.0011	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000147	0.00107	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000145	0.00106	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000144	0.00105	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.00014	0.00102	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—EGFR—chronic obstructive pulmonary disease	0.000138	0.00101	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000132	0.000963	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—EGFR—chronic obstructive pulmonary disease	0.000131	0.000954	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00013	0.000952	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000129	0.000938	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000125	0.00091	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000122	0.00089	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00012	0.000878	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000116	0.000845	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000115	0.000838	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000113	0.000827	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000109	0.000796	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—IL6—chronic obstructive pulmonary disease	0.000106	0.000776	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL1B—chronic obstructive pulmonary disease	0.000106	0.000771	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000105	0.000767	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000102	0.000742	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000102	0.000742	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000101	0.00074	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IL6—chronic obstructive pulmonary disease	0.000101	0.000733	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000101	0.000733	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.0001	0.000732	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL1B—chronic obstructive pulmonary disease	0.0001	0.00073	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.35e-05	0.000682	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.22e-05	0.000673	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.87e-05	0.000647	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.74e-05	0.000638	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	8.15e-05	0.000595	CbGpPWpGaD
Olopatadine—S100A12—Immune System—EGFR—chronic obstructive pulmonary disease	8.06e-05	0.000588	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	8.05e-05	0.000587	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.96e-05	0.000581	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	7.71e-05	0.000562	CbGpPWpGaD
Olopatadine—S100B—Immune System—EGFR—chronic obstructive pulmonary disease	7.62e-05	0.000556	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.6e-05	0.000554	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	7.27e-05	0.00053	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	7.13e-05	0.00052	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.74e-05	0.000492	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	6.6e-05	0.000481	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	6.49e-05	0.000474	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	6.21e-05	0.000453	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	6.21e-05	0.000453	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL6—chronic obstructive pulmonary disease	6.19e-05	0.000452	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	6.19e-05	0.000451	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.1e-05	0.000445	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.9e-05	0.00043	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL6—chronic obstructive pulmonary disease	5.86e-05	0.000427	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.68e-05	0.000414	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.48e-05	0.000399	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	5.16e-05	0.000376	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.03e-05	0.000367	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.93e-05	0.000359	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.73e-05	0.000345	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	4.6e-05	0.000335	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.54e-05	0.000331	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.27e-05	0.000312	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.22e-05	0.000308	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.14e-05	0.000302	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.9e-05	0.000284	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.79e-05	0.000276	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.51e-05	0.000256	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.48e-05	0.000254	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.19e-05	0.000232	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.17e-05	0.000231	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.05e-05	0.000222	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.83e-05	0.000207	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.51e-05	0.000183	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	2.48e-05	0.000181	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.33e-05	0.00017	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	2.27e-05	0.000165	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.22e-05	0.000162	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.12e-05	0.000155	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.09e-05	0.000152	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.88e-05	0.000137	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.79e-05	0.000131	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.74e-05	0.000127	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.72e-05	0.000125	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.7e-05	0.000124	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.6e-05	0.000117	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.53e-05	0.000112	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.52e-05	0.000111	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.4e-05	0.000102	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.38e-05	0.0001	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.16e-05	8.43e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.06e-05	7.71e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.03e-05	7.52e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	9.86e-06	7.19e-05	CbGpPWpGaD
